A new drug capable of leveling out a double chin will be reviewed by the US Food and Drug Administration (FDA) on March 9, according to Kythera Biopharmaceuticals, which is to market the drug should it get the nod.
Will the bellwether company’s collaboration spark a trend among other large medical device players?
By Marie Thibault
Recently, healthcare heavyweight Johnson & Johnson announced it would share clinical trial data on its medical devices and diagnostics with the Yale University Open Data Access (YODA) Project. The company is the first in the medical technology industry to offer this kind of data sharing, and its collaboration with the Yale project already includes access to drug trial data.
Do you have any queries?